September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of both native and pathological vascular changes occurring during the Aflibercept intravitreal injections' loading phase in treatment-naïve wet AMD patients.
Author Affiliations & Notes
  • Enrico Borrelli
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Lisa Toto
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Paolo Carpineto
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Rodolfo Mastropasqua
    Ophthalmology Unit, Department of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, 53593 Verona, Italy, Verona, Italy
  • Luca Di Antonio
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Michele Palmieri
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Filomena Pinto
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Leonardo Mastropasqua
    Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy, Chieti, Italy
  • Footnotes
    Commercial Relationships   Enrico Borrelli, None; Lisa Toto, None; Paolo Carpineto, None; Rodolfo Mastropasqua, None; Luca Di Antonio, None; Michele Palmieri, None; Filomena Pinto, None; Leonardo Mastropasqua, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 518. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Enrico Borrelli, Lisa Toto, Paolo Carpineto, Rodolfo Mastropasqua, Luca Di Antonio, Michele Palmieri, Filomena Pinto, Leonardo Mastropasqua; Evaluation of both native and pathological vascular changes occurring during the Aflibercept intravitreal injections' loading phase in treatment-naïve wet AMD patients.. Invest. Ophthalmol. Vis. Sci. 2016;57(12):518.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate vessel changes occurring after Aflibercept injections in treatment-naïve exudative age-related macular degeneration (AMD) patients.

Methods : Fifteen eyes of 15 patients affected by wet AMD were enrolled in the study. All the patients had a diagnosis of type 1 choroidal neovascularization (CNV) and were treated with three monthly Aflibercept intravitreal injections (IVI). Subjects were evaluated by means of Optical Coherence Tomography Angiography (OCTA) at baseline, the day after the first injection and one month after both the first and the second IVI. At last, all the patients were followed up to 2 months after the 3rd IVI. Main outcomes were: (i) superficial plexus vessel density; (ii) choroidal thickness; (iii) CNV lesion area; and (iv) CNV flow area.

Results : Foveal superficial vessel density was 29,01% (21,13 to 37,32%) at baseline and was significantly reduced as soon as 1 month after the 1st IVI (median: 20,78%; IQR: 14,75 to 23,13%; p=0,017). Parafoveal superficial vessel density was 47,09% (44,91 to 51,72%) at baseline and significantly decreased as soon as 1 month after the 2nd IVI (median: 44,40%; IQR: 41,59 to 49,29%; p=0,034). Choroidal sub-foveal thickness was 185,50 μm (140,25 to 254,25 μm) at baseline and was significantly thinned as soon as 1 month after the 1st IVI (median: 147,50 μm; IQR: 125,50 to 192,75 μm; p=0,036). CNV lesion area remained stable throughout the follow-up. Nevertheless, interestingly, CNV flow area was significantly reduced as soon as the next day the 1st IVI (median: 0,37 mm2 and IQR: 0,27 to 0,72 mm2 at baseline; median: 0,30 mm2 and IQR: 0,24 to 0,64 mm2 at 1 day after the 1st IVI; p=0,047).

Conclusions : Intravitreal Aflibercept injections caused a significant change in native retinal and choroidal vasculature. Moreover, the treatment did not cause a reduction in lesion area, but rather reduced the flow in the CNV. Our results give credit to the theory that, in most cases, the treatment does not lead to a reduction in the size of CNV, but rather reduces the number and the perfusion of the smallest pathological vessels.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×